HBsAg and HBV DNA levels guiding entecavir cessation in HBeAg-negative chronic hepatitis B

被引:0
|
作者
Seto, Wai-Kay
Hui, Aric Josun
Wong, Vincent Wai-Sun
Wong, Grace Lai-Hung
Liu, Kevin
Lai, Ching-Lung
Yuen, Man-Fung
Chan, Henry Lik-Yuen
机构
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
关键词
hepatitis B; nucleoside analogue; treatment cessation; HBsAg;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:414 / 414
页数:1
相关论文
共 50 条
  • [1] HBsAg Kinetics Prior to HBsAg Loss after Cessation of Entecavir Therapy in Hbeag-Negative Chronic Hepatitis B Patients
    Jeng, Wen-Juei
    Chang, Ming-Ling
    Liaw, Yun-Fan
    HEPATOLOGY, 2018, 68 : 272A - 272A
  • [2] Hepatitis B virus DNA suppression with entecavir therapy in a HBeAg-negative decompensated chronic HBV
    Muneer, Badar
    Mohanty, Smruti R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S242 - S242
  • [3] SERUM HBSAG LEVELS REFLECT INTRACELLULAR HBSAG, BUT NOT CCCDNA OR TOTAL LIVER HBV DNA IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    Tiniakos, Dina
    Hadziyannis, Emilia
    Agelopoulou, Olga P.
    Syminelaki, Thalia
    Papaioannou, Christos
    Nastos, Theodoros
    Karayannis, Peter
    HEPATOLOGY, 2009, 50 (04) : 969A - 970A
  • [4] HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B
    Zhang, Chong
    Yang, Zhengrong
    Wang, Ziyi
    Dou, Xiaoguang
    Sheng, Qiuju
    Li, Yanwei
    Han, Chao
    Ding, Yang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (03): : 383 - 389
  • [5] Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients
    Keshvari, Maryam
    Alavian, Seyed Moayed
    Sharafi, Heidar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (03)
  • [6] HBV DNA Levels Predict Significant Liver Histology for HBeAg-Negative Chronic Hepatitis B Patients
    Seto, Wai Kay
    Lai, Ching-Lung
    Fung, James
    Yuen, John
    Wong, Danny K. H.
    Yuen, Man-Fung
    GASTROENTEROLOGY, 2010, 138 (05) : S788 - S788
  • [7] STRATIFICATION OF HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS THROUGH LONGITUDINAL MONITORING OF HBV DNA LEVELS
    Lee, Hae Lim
    Lee, Sung Won
    Jang, Jeong Won
    Yang, Hyun
    Nam, Heechul
    Sung, Pil Soo
    Song, Do Seon
    Kwon, Jung Hyun
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    HEPATOLOGY, 2024, 80 : S178 - S178
  • [8] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [9] Does HBV DNA level predict outcome in HBeAg-negative chronic hepatitis B?
    Feld, JJ
    Tellier, R
    Ayers, M
    El-Ashry, D
    Arenovich, T
    Mazzuli, A
    Heathcote, EJ
    GASTROENTEROLOGY, 2005, 128 (04) : A739 - A739
  • [10] HBSAG SEROCOVERSION UNDER LAMIVUDINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Seven, Gulseren
    Idilman, Ramazan
    Bozkus, Yusuf
    Cinar, Kubilay
    Kabacam, Gokhan
    Yakut, Mustafa
    Bozdayi, A. Mithat
    Yurdaydin, Cihan
    HEPATOLOGY, 2010, 52 (04) : 545A - 546A